Page last updated: 2024-10-24

butalbital and Infant, Newborn, Diseases

butalbital has been researched along with Infant, Newborn, Diseases in 1 studies

butalbital: management of butalbital withdrawal can be simplified by using a phenobarbital-loading protocol; RN given refers to parent cpd
butalbital : A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. Frequently combined with other medicines, such as aspirin, paracetamol and codeine, it is used for treatment of pain and headache.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ostrea, EM1

Other Studies

1 other study available for butalbital and Infant, Newborn, Diseases

ArticleYear
Neonatal withdrawal from intrauterine exposure to butalbital.
    American journal of obstetrics and gynecology, 1982, Jul-01, Volume: 143, Issue:5

    Topics: Barbiturates; Chromatography, Gas; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male;

1982